期刊文献+

我院临床药师参与156例感染病例会诊回顾性分析 被引量:4

Retrospectively Analyzed of Clinical Pharmacists to Participate in the Consultation of 156 Infection Cases
下载PDF
导出
摘要 目的:总结我院临床药师参与感染病例会诊的经验,促进儿科临床药师更好地为患儿服务。方法:采用回顾性研究方法,对2014-2015年我院临床药师参与的所有感染病例会诊情况进行分析,内容包括患儿年龄分布、科室分布、申请药师会诊理由、会诊模式、病原学检查结果、药师建议采纳情况、患儿病情转归情况等。结果:2014-2015年我院临床药师共参与感染病例会诊156例,患儿年龄6 h^15岁,其中1岁以内占60.26%(94/156);涉及12个临床科室,其中儿外科63例(40.38%),儿内科93例(59.62%);申请药师会诊理由以指导选择、调整抗菌药物为主,占96.15%(150/156);会诊模式分为普通会诊、急会诊、多学科会诊、院内大会诊四种模式;病原学检查结果阳性患儿共79例(50.64%);药师建议全部采纳119例(76.28%),部分采纳18例(11.54%),未采纳19例(12.18%);追踪观察108例患儿病情转归情况,临床药师参与会诊的治疗总有效率为94.44%(102/108)。结论:儿科临床药师在临床诊疗活动中的地位越来越得到认可,但仍需要不断学习临床医学及药学知识,以便更好地为临床服务、为患儿服务。 Objective: To summarize clinical pharmacists to participate in the consultation of infection cases,promote better service to the children. Methods: All of our hospital from 2014 to 2015 cases of the clinical pharmacists to participate in the consultation,including the age distribution,department distribution,reasons of consultation,consultation mode,results of etiological examination,adopted situation of suggestion,and disease outcome were retrospectively analyzed. Results: Clinical pharmacists were participated in the consultation of 156 infection cases. The children's age was 6 hours to 15 years. There were 63 cases in surgery,93 cases in medicine. Consultation reasons were given priority to instruction selection,adjustment of antimicrobial agents,accounted for 96. 15%.There were 79 cases of positive etiological examination. Consultation opinion all adopted with 119 cases( 76. 28%),parts adopted 18cases( 11. 54%),19 cases didn 't adopt( 12. 18%) respectively. Conclusion: Clinical pharmacists in the clinical diagnosis and treatment status are more and more sure,but clinical pharmacists still need to keep learning clinical and pharmaceutical knowledge,in order to better clinical services for children.
机构地区 徐州市儿童医院
出处 《儿科药学杂志》 CAS 2016年第11期35-38,共4页 Journal of Pediatric Pharmacy
关键词 儿科 临床药师 感染疾病 会诊 pediatric clinical pharmacists infectious disease consultation
  • 相关文献

参考文献7

二级参考文献30

  • 1吴永佩,颜青,蒋学华,曾仁杰,甄健存.临床药师任职技术(准入)条件的探讨[J].中国药房,2005,16(7):484-487. 被引量:42
  • 2MHLW.抗菌藥臨床評価のガィドラィン[EB/OL].http://www.mhlw.go.jp,1998-08-25.
  • 3FDA. Guidance for industry: Evaluating clinical studies of antimicrobials in the division of anti -infective drugs products[ EB/OL]. http:// www. fda. gov/cder/guidance/draft 9 al. pdf, 1997 - 02 - 18.
  • 4Smith C, Burley C, Ireson M, et al. Clinical trials of antibacterial agents : a practical guide to design and analysis [ J ]. J Antimicrob Chemother, 1998; 41 : 467 - 480.
  • 5EMEA. Note for Guidance on evaluation of medicinal products indicated for treatment of bacterial infections [ EB/OL ]. http ://www. emea. euro- pa. eu/pdfs/human/ewp/055895 en. pdf,2004 - 04 - 22.
  • 6Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 8Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 9Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 10Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.

共引文献726

同被引文献15

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部